Evidence map›Paper›PMID 37675047›Full record

ArticleFrontiers in pharmacology2023

Editorial: Exploring the therapeutic effects of synthetic, semi-synthetic and naturally derived compounds against cancer.

Liang Feng, Junfei Gu, Yanjun Yang, Bing Yang, Ruyu Shi

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Enhanced Inhibition ofInternational journal of molecular sciences · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Liang FengState Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
Junfei GuSchool of Chinese Medicine, School of Integrated Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Yanjun YangState Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
Bing YangState Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.
Ruyu ShiState Key Laboratory of Natural Medicines, Department of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

action mechanismsanticancerchemopreventive agentnatural medicinepotential target discovery

Identifiers

PMID37675047
PMCPMC10478079

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.